March 13, 2003
View Full PaperTreatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07
Key Points
Key points are not available for this paper at this time.
Abstract
These results indicate that high-dose methotrexate is associated with modest toxicity and a radiographic response proportion (74%) comparable to more toxic regimens.
Cite This Study
Batchelor et al. (Thu,) studied this question.